July 5, 2006 - 2:41pm
On June 28, 2006, the FDA approved Sprycel (dasatinib), a new drug that treats two forms of leukemia. Sprycel is made by Bristol-Myers Squibb Company.
Sprycel is an important new treatment option for patients who have stopped responding to other medication. For more information, please see Bristol-Myers Squibb's press release.
Pill Identification - Sprycel
20 mg: White to off-white, biconvex, round, film-coated tablet with BMS debossed on one side and 527 on the other side
50 mg: White to off-white, biconvex, oval, film-coated tablet with BMS debossed on one side and 528 on the other side
70 mg: White to off-white, biconvex, round, film-coated tablet with BMS debossed on one side and 524 on the other side
good information on the medication!